SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-22-017681
Filing Date
2022-05-04
Accepted
2022-05-04 18:47:47
Documents
2
Period of Report
2022-04-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 2036
2 EXHIBIT 24.1 brhc10037174_24-1.htm EX-24.1 7374
  Complete submission text file 0001140361-22-017681.txt   10938
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address
Hoffman David Andrew (Reporting) CIK: 0001926436 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37853 | Film No.: 22893291